Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-006460

Chief Financial Officer sold 10,000 shares at $215.22 ($2,152,196)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2023-02-17 Sale −10,000 $215.22 $2,152,196 106,880 D: show line 1 in the form
Open-market sales · 10,000 sh · avg $215.22 · $2,152,196
Loading xslF345X03/form4.xml…